Search Login Register

ziprasidone (Geodon) Summary

Description: a benzisothiazoylpiperazine derivative; has combined dopamine and serotonin receptor antagonist activity; structurally related to tiospirone

Also Known As: Geodon; 5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one; CP 88059; CP 88059-01; CP-88,059 Show All >>

Networked: 741 relevant articles (111 outcomes, 252 trials/studies) for this Drug

Key Diseases for which ziprasidone is Relevant

  1. Schizophrenia (Dementia Praecox) : 55 outcomes 157 studies in 320 results
  2. Bipolar Disorder (Mania) : 28 outcomes 46 studies in 126 results
  3. Psychotic Disorders (Schizoaffective Disorder) : 13 outcomes 50 studies in 95 results
  4. Weight Gain : 6 outcomes 18 studies in 103 results
  5. Weight Loss (Weight Reduction) : 3 outcomes 1 study in 12 results
Show All >>

Drugs Related to ziprasidone

  1. olanzapine (Zyprexa)
  2. Risperidone (Risperdal Consta)
  3. quetiapine (Seroquel)
  4. Antipsychotic Agents (Antipsychotics)
  5. aripiprazole (Abilify)
  6. Clozapine (Clozaril)
  7. Haloperidol (Haldol)
  8. sultopride (amisulpride)
  9. Cholesterol
  10. Valproic Acid (Valproate, Semisodium)
Show All >>

Therapies Related to ziprasidone

  1. Drug Therapy (Chemotherapy)
  2. Hormone Replacement Therapy (Therapy, Hormone Replacement)
  3. Intramuscular Injections
  4. Off-Label Use
  5. Stents
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.